First-in-human trial demonstrates promise of implantable cytokine factories for ovarian cancer
Implantable cytokine factories designed to deliver immunotherapy directly at the site of disease have taken an important step toward clinical reality. Researchers at Rice University, in collaboration with The University of ...
May 12, 2026
0
3









